Some of the health care transformations that were forced by the COVID-19 pandemic could continue to benefit patients and the health care system, Jacques Sokolov, MD, said during his keynote address at the National Association of Managed Care Physicians (NAMCP) Spring Managed Care Forum 2023.
Researchers are beginning work on a double-blind randomized controlled trial to test the results of this preliminary study.
Eric Lisle, president and CEO of Southeast Primary Care Partners, discusses the importance of comprehensive patient data for primary care practices implementing value-based care.
Accelerating the safe implementation guideline-directed medical therapy has also been shown to reduce heart failure–related morbidity and mortality, underscoring the need for more integration into current care.
Although obesity and male sex serve as the main risk factors for obstructive sleep apnea, study results have also shown smoking increases the risk of the condition.
Researchers set out to collect empirical evidence on how a capitated risk-based county plan performs as a viable public option in the Affordable Care Act (ACA) marketplace in California
Type 2 diabetes drug tirzepatide (Mounjaro) helped some individuals lose nearly 16% of their body weight; some vital drugs have been sporadically in shortage for over 8 years; a bacterial outbreak of klebsiella claimed 4 lives and infected 31 people in a Seattle hospital.
The study examined the prevalence of prescription medications in jails and state prisons for individuals with chronic conditions, such as asthma, type 2 diabetes, hypertension, hepatitis B and C, HIV infection, depression, and severe mental illness, compared with the general population.
The American Society for Radiation Oncology (ASTRO) and European Society for Radiotherapy and Oncology (ESTRO) jointly released a clinical guideline on the use of definitive local therapy for the treatment of oligometastatic non–small cell lung cancer (NSCLC).
Investigators found patients with acute coronary syndrome were 3 times more likely to die in the hospital.
These study results are the first to demonstrate randomized evidence that a personalized neoantigen approach could be beneficial for patients with cancer.
The antibody drug conjugate received FDA approval in November 2022.
Researchers found that eyeglasses with traditional steps of 0.25D were less effective and less preferred by participants compared with those refracted in 0.05D steps.
The MiniMed 780G system has been approved for children aged 7 years and up with type 1 diabetes (T1D), according to Medtronic.
A recent study found that HIV is 2.5 times more common in people who use mental health services compared with the general population in South London.
The deal creates a new force in the world of value-based health care.
The data highlight that silent cerebral infarcts represent just a portion of brain injury that occurs in patients with sickle cell disease (SCD), and brain volume can serve as another potential biomarker of brain injury in those with the disease.
FDA accelerates approval of drug for amyotrophic lateral sclerosis (ALS); hundreds of thousands could lose Medicaid coverage under Republican debt bill including work requirements; the Department of Veterans Affairs (VA) reports that half a million veterans have filed claims for health benefits related to toxic exposures.
In this phase 1 trial, researchers sought to investigate whether ruxolitinib cream is safe and tolerable in children aged 2 to 17 with atopic dermatitis (AD).
The Revolutionizing Atopic Dermatitis conference, set to begin on April 29 in Washington, DC, promises to offer symposia on emerging therapies and new insights into treating atopic dermatitis (AD).
The potential ethical implications for goals of care discussions between surrogate decision makers and health care providers concerning patients who reside in a state of cognitive motor dissociation were investigated in this new study from a team at Columbia University and New York Presbyterian Hospital.
People with myasthenia gravis (MG) had a higher risk of hospitalization for COVID-19 compared to the general population and a control group of people with rheumatoid arthritis (RA).
Improved survival rates suggest long-term noninvasive therapy (LTH-NIV) may benefit patients with acute hypercapnic exacerbations of chronic obstructive pulmonary disorder (AECOPD).
A new literature review underscores how acne is separate from acne vulgaris and requires a comprehensive clinical approach unique from those for active acne.
Several presentations at the 2023 Asembia Specialty Pharmacy Summit, held in Las Vegas, Nevada, from April 30 through May 4, will cover how to address health equity concerns in specialty pharmacy care, the expansion of the biosimilars market, and the impact of the Inflation Reduction Act (IRA) on the US health care system.
Much more work needs to be done surrounding multiple sclerosis (MS) and treating pregnant patients safely, noted Mitzi Joi Williams, MD, FAAN, medical director and CEO, Joi Life Wellness Neurology Clinic.
Milena Pavlova, MD, neurologist and medical director of the sleep testing center at Brigham and Women’s Faulkner Hospital, discusses the profound effect obstructive sleep apnea has on epilepsy as well as cognition.
A nomogram that could assist physicians in predicting severe respiratory syncytial virus (RSV)–associated bronchiolitis early on was established and validated in a recent study.
At Asembia 2023, there will be a call to action for participants to adjust their current business models and advocate for access to biosimilars with lower list costs, explained Julie Reed, executive director of the Biosimilars Forum.
Two-year data on MRI, efficacy, and safety findings from the long-term safety extension study of the investigational Bruton tyrosine kinase (BTK) inhibitor tolebrutinib for relapsing multiple sclerosis were presented in a pair of posters at the American Academy of Neurology 2023 annual meeting.
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.
